Tzeplaeff L, Galhoz A, Meijs C, Caldi Gomes L, Kovac A, Menzel A, Değirmenci H, Alaamel A, Kaya HC, Çelik AG, Dinçer S, Korucuk M, Karaüzüm SB, Bayraktar E, Çiftçi V, Bilge U, Koç F, Demleitner AF, Buchberger A, von Heynitz R, Gmeiner V, Knellwolf C, Mouzouri M, Wuu J, Başak AN, Andersen PM, Kohlmayer F, Ashton NJ, Kuban W, Lenz C, Rogers ML, Zilka N, Corcia P, Lerner Y, Weber M, Turcanova Koprusakova M, Uysal H, Benatar M, Menden MP, Lingor P. Identification of a presymptomatic and early disease signature for amyotrophic lateral sclerosis (ALS): protocol of the premodiALS study. Neurol Res Pract. 2025 Aug 19;7(1):56. [PubMed link]
Recent Posts
- Feature: UHealth’s Qalsody Clinic Provides Cutting-Edge Care for ALS Patients
- The New York Times Feature: In a Milestone for A.L.S., a Treatment Helps Some Patients Improve
- CReATe Author Series Ep. 18 – Dr. Michael Benatar on MMI as a prodromal stage of ALS
- Walk to Defeat ALS Miami 2026
- Save the Date! 2026 Annual ALS Patient Symposium
Recent Comments